Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReCure: Second Uterine Evacuation vs Chemotherapy in GTN
NCT04756713Phase 3Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Feb 2021
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Rate of primary remission at 3 years. Started Feb 2021; status: recruiting.
Beyond the preview
Go deeper on NCT04756713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04756713.